[vii] Park SA, Byeon G, Jhoo JH, Kim HC, Lim MN, Jang JW, Bae JB, Han JW, Kim TH, Kwak KP, Kim BJ, Kim SG, Kim JL, Moon SW, Park JH, Ryu SH, Youn JC, Lee DW, Lee SB, Lee JJ, Lee DY, Kim KW
J Photochem.Photobiol.B 7-2-2012;112:7-15
Our Weight & Wellness program pairs the proven benefits of weekly weight loss injections with one-on-one support, including personalized health benchmarking and private check-ins with trusted providers as you achieve your goals
The dual GIP/GLP-1 agonist: stronger than anything else Tirzepatide is the first and so far only approved member of a new class: a dual agonist that activates two receptors at once
Patients using GLP-1s to control diabetes have higher adherence and persistency than GLP-1s used for weight loss